What is the treatment for Candida albicans noted on urine culture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Candida Albicans in Urine Culture

For symptomatic Candida albicans urinary tract infections, oral fluconazole 200 mg daily for 2 weeks is the recommended first-line treatment. 1

Determining Treatment Necessity

Before initiating treatment, it's crucial to determine whether the candiduria requires intervention:

  • Asymptomatic candiduria: Generally does NOT require treatment 1, 2

    • Funguria resolves without treatment in approximately 76% of cases 1
    • Exception: Treatment is warranted in high-risk patients including:
      • Neutropenic patients
      • Very low birth weight infants
      • Patients undergoing urologic procedures
      • Patients with suspected disseminated infection 2
  • Symptomatic candiduria: Requires treatment with appropriate antifungal therapy 1

First Step: Remove Predisposing Factors

The most important initial intervention is to address underlying factors:

  • Remove indwelling bladder catheters whenever possible (strongly recommended) 1, 2
    • This alone resolves candiduria in approximately 50% of cases 3
  • Eliminate urinary tract obstruction if present (strongly recommended) 1
  • Remove or replace nephrostomy tubes/stents if present 1
  • Discontinue unnecessary antibiotics that may promote fungal overgrowth 3

Treatment Algorithm Based on Susceptibility

For Fluconazole-Susceptible C. albicans:

  1. Oral fluconazole 200 mg daily for 2 weeks (strong recommendation) 1
    • Fluconazole achieves high urinary concentrations 4
    • Success rate around 50% 2

For Fluconazole-Resistant C. albicans or C. glabrata:

  1. Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days (strong recommendation) 1 OR
  2. Oral flucytosine 25 mg/kg 4 times daily for 7-10 days (strong recommendation) 1

For Complicated Cases (Fungus Balls or Renal Abscesses):

  1. Surgical intervention is strongly recommended 1, 2
  2. Combine with appropriate systemic antifungal therapy as noted above 1
  3. Consider irrigation through nephrostomy tubes with amphotericin B deoxycholate (25-50 mg in 200-500 mL sterile water) if present 1

Important Considerations and Pitfalls

  • Echinocandins (caspofungin, micafungin) should NOT be used for uncomplicated fungal UTIs due to poor urinary concentrations 2, 3

    • Exception: May be considered when infection has invaded renal tissue rather than being limited to the collecting system 2
  • Newer azole antifungals (beyond fluconazole) are NOT recommended for urinary tract infections due to inadequate urine concentrations 3

  • Diagnostic pitfall: Ensure proper collection technique to avoid contamination, as candiduria in outpatients is often due to sample contamination 5

  • Follow-up cultures should be obtained to confirm eradication after treatment completion 2

  • Duration of therapy: Typically 2 weeks for uncomplicated infections, or until symptoms resolve and urine cultures become negative 2

By following this evidence-based approach, most cases of Candida albicans urinary tract infections can be effectively managed with appropriate antifungal therapy after addressing underlying predisposing factors.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Fungal Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Candida urinary tract infections: treatment options.

Expert review of anti-infective therapy, 2007

Research

Candida urinary tract infections in adults.

World journal of urology, 2020

Research

Candida urinary tract infections--epidemiology.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.